You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer
|
|---|---|
| Published in |
Investigational New Drugs, August 2004
|
| DOI | 10.1023/b:drug.0000026256.38560.be |
| Pubmed ID | |
| Authors |
Eardie A. Curry, Daryl J. Murry, Christy Yoder, Karen Fife, Victoria Armstrong, Harikrishna Nakshatri, Michael O’Connell, Christopher J. Sweeney |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 2% |
| Unknown | 50 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 8 | 16% |
| Student > Bachelor | 7 | 14% |
| Other | 6 | 12% |
| Researcher | 6 | 12% |
| Professor > Associate Professor | 5 | 10% |
| Other | 9 | 18% |
| Unknown | 10 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 15 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
| Medicine and Dentistry | 5 | 10% |
| Chemistry | 4 | 8% |
| Biochemistry, Genetics and Molecular Biology | 4 | 8% |
| Other | 8 | 16% |
| Unknown | 10 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2021.
All research outputs
#3,798,287
of 25,371,288 outputs
Outputs from Investigational New Drugs
#104
of 1,262 outputs
Outputs of similar age
#6,306
of 61,344 outputs
Outputs of similar age from Investigational New Drugs
#1
of 9 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,262 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 61,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them